CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 87 enrolled
Drug / intervention
CPO Pro IOL +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06400745
NCT06400745N/ACompleted
CompareCT.gov

Contralateral Study of Clareon PanOptix Pro vs. Clareon PanOptix

Alcon Research·interventional·Posted May 6, 2024·Updated Dec 12, 2025

In Brief

A clinical study evaluating CPO Pro IOL, CPO IOL, and 1 other intervention for Aphakia and Presbyopia. Completed, enrolled 87 participants across 8 sites.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAphakia, Presbyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedMay 6, 2024
Enrollment StartJun 18, 2024
Primary CompletionDec 13, 2024
Study CompletionApr 30, 2025
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 2.2 years ago

Interventions

CPO Pro IOLdevice

Intraocular lens (IOL) implanted in the eye for the visual correction of aphakia in adult patients with less than 1 diopter of preexisting corneal astigmatism in whom a cataractous lens has been removed. The IOL is intended to mitigate the effects of presbyopia on intermediate and near visual acuity while maintaining comparable distance visual acuity.

CPO IOLdevice

Intraocular lens (IOL) implanted in the eye for the visual correction of aphakia in adult patients with less than 1 diopter of preexisting corneal astigmatism in whom a cataractous lens has been removed. The IOL is intended to mitigate the effects of presbyopia on intermediate and near visual acuity while maintaining distance visual acuity.

Cataract surgeryprocedure

Extraction of the cataractous lens by phacoemulsification, followed by implantation of the IOL.